I'm LongbridgeAI, I can summarize articles.Cigna (CI) rose 1.31% this week to close at $282.52, outperforming the S&P 500 by roughly 1.22 percentage points. Trading was choppy: the stock opened lower on Monday, dipped to a weekly low of $275.59, then bounced from Tuesday, peaked at $286.81 on Thursday, and settled back to $282.52 on Friday. The weekly range was 4.02%. Daily volume averaged 1.42m shares, about 1.52% below the 60-day median, so turnover stayed moderate.
The Week
Cigna (CI) rose 1.31% this week to close at $282.52, outperforming the S&P 500 by roughly 1.22 percentage points. Trading was choppy: the stock opened lower on Monday, dipped to a weekly low of $275.59, then bounced from Tuesday, peaked at $286.81 on Thursday, and settled back to $282.52 on Friday. The weekly range was 4.02%. Daily volume averaged 1.42m shares, about 1.52% below the 60-day median, so turnover stayed moderate.
Key Events
There were no major company filings or regulatory updates this week. News flow skewed towards industry and market comparisons. On 31 August, the Roxbury Institute announced in-network Cigna access starting 15 October for eligible patients seeking specialised lipedema care in California. On 1-2 September, market briefs compared Cigna with peers across healthcare plans, noting underperformance on Monday and outperformance on Tuesday. On 2 September, Bill Ackman backed Mark Cuban’s drug pricing model, with healthcare stocks mentioned as potential winners or losers. On 3 September, a long-term return piece highlighted the cumulative return on $100 invested 20 years ago.
Analyst Ratings
As of this week, 24 institutions cover Cigna: 13 rate it buy, 6 overweight, and 5 hold, with no underweight or sell ratings. The consensus rating is buy, with a consensus target of $341.42, about 20.85% above the weekly close. Targets range from $290 to $400, suggesting meaningful dispersion. Among 53 healthcare services companies, Cigna ranks third by analyst rating.
The Week Ahead
US macro data dominates 8-10 September. On 8 September, the NFIB Small Business Optimism Index is due. On 10 September, a busier slate includes initial jobless claims, final demand PPI and its core ex-food-and-energy reading, existing home sales, wholesale sales, EIA natural gas storage change, and the 10-year Treasury auction’s high yield and bid-to-cover ratio. Healthcare services remain sensitive to rates and inflation, so Treasury yields and PPI prints are worth tracking.
In Short
Cigna beat the broader market this week. The consensus rating stays at buy, with the consensus target about 20.85% above spot, and the stock ranks high within its industry. Valuation sits at roughly 11.6x P/E and 1.75x P/B, with a dividend yield around 2.17%. On the latest trading day, retail investors were net buyers while large-lot money turned slightly net seller. The focus now shifts to the 10-year yield and inflation data, and how they affect healthcare services valuations.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.